Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia.

Kikushige Y, Ishikawa F, Miyamoto T, Shima T, Urata S, Yoshimoto G, Mori Y, Iino T, Yamauchi T, Eto T, Niiro H, Iwasaki H, Takenaka K, Akashi K.

Cancer Cell. 2011 Aug 16;20(2):246-59. doi: 10.1016/j.ccr.2011.06.029.

2.

Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.

Hashimoto S, Dono M, Wakai M, Allen SL, Lichtman SM, Schulman P, Vinciguerra VP, Ferrarini M, Silver J, Chiorazzi N.

J Exp Med. 1995 Apr 1;181(4):1507-17.

4.

Detection of trisomy 12 and Rb-deletion in CD34+ cells of patients with B-cell chronic lymphocytic leukemia.

Gahn B, Schäfer C, Neef J, Troff C, Feuring-Buske M, Hiddemann W, Wörmann B.

Blood. 1997 Jun 15;89(12):4275-81.

5.

IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.

Wakai M, Hashimoto S, Omata M, Sthoeger ZM, Allen SL, Lichtman SM, Schulman P, Vinciguerra VP, Diamond B, Dono M, et al.

Autoimmunity. 1994;19(1):39-48.

PMID:
7538331
6.

Biology of the neoplastic lymphocyte in B-CLL.

Dighiero G.

Baillieres Clin Haematol. 1993 Dec;6(4):807-20. Review.

PMID:
8038491
7.
8.

[Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].

Rupniewska ZM, Wach M, Kowal M, Roliński J, Antosz H.

Acta Haematol Pol. 1992;23(1):21-7. Review. Polish.

PMID:
1615748
10.
11.
12.
13.

Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia.

Kipps TJ, Tomhave E, Pratt LF, Duffy S, Chen PP, Carson DA.

Proc Natl Acad Sci U S A. 1989 Aug;86(15):5913-7.

14.

Myelo-monocytoid immunophenotypes of B-cell chronic lymphocytic leukemia cells.

Tsuda H, Matsumi S, Nishimura H, Kawano F, Shido T, Takatsuki K.

Intern Med. 1993 Jul;32(7):533-9.

15.

Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.

Jelinek DF, Tschumper RC, Geyer SM, Bone ND, Dewald GW, Hanson CA, Stenson MJ, Witzig TE, Tefferi A, Kay NE.

Br J Haematol. 2001 Dec;115(4):854-61.

PMID:
11843819
16.

SCL expression at critical points in human hematopoietic lineage commitment.

Zhang Y, Payne KJ, Zhu Y, Price MA, Parrish YK, Zielinska E, Barsky LW, Crooks GM.

Stem Cells. 2005 Jun-Jul;23(6):852-60.

17.

Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype.

Segel GB, Woodlock TJ, Xu J, Li L, Felgar RE, Ryan DH, Lichtman MA, Wang N.

Blood Cells Mol Dis. 2003 May-Jun;30(3):277-87.

PMID:
12737946
18.

Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.

Decker T, Schneller F, Sparwasser T, Tretter T, Lipford GB, Wagner H, Peschel C.

Blood. 2000 Feb 1;95(3):999-1006.

19.

Molecular analysis of rearranged VH genes during B cell chronic lymphocytic leukemia: intraclonal stability is frequent but not constant.

Korganow AS, Martin T, Weber JC, Lioure B, Lutz P, Knapp AM, Pasquali JL.

Leuk Lymphoma. 1994 Jun;14(1-2):55-69.

PMID:
7920229
20.

Immunoglobulin V gene expression in CD5 B-cell malignancies.

Kipps TJ, Rassenti LZ, Duffy S, Johnson T, Kobayashi R, Carson DA.

Ann N Y Acad Sci. 1992 May 4;651:373-83. Review.

PMID:
1376056

Supplemental Content

Support Center